Your browser is no longer supported. Please, upgrade your browser.
Settings
ONVO Organovo Holdings, Inc. daily Stock Chart
ONVO [NASD]
Organovo Holdings, Inc.
Index- P/E- EPS (ttm)-0.23 Insider Own0.70% Shs Outstand135.16M Perf Week-9.17%
Market Cap57.06M Forward P/E- EPS next Y-0.25 Insider Trans- Shs Float122.79M Perf Month-9.20%
Income-26.60M PEG- EPS next Q-0.06 Inst Own38.50% Short Float10.84% Perf Quarter-57.78%
Sales3.10M P/S18.41 EPS this Y28.90% Inst Trans13.50% Short Ratio6.38 Perf Half Y-56.19%
Book/sh0.30 P/B1.41 EPS next Y0.00% ROA-63.40% Target Price2.50 Perf Year-71.66%
Cash/sh0.27 P/C1.56 EPS next 5Y- ROE-70.00% 52W Range0.37 - 1.50 Perf YTD-55.89%
Dividend- P/FCF- EPS past 5Y8.20% ROI-75.10% 52W High-70.71% Beta1.76
Dividend %- Quick Ratio10.20 Sales past 5Y52.20% Gross Margin84.40% 52W Low18.70% ATR0.09
Employees61 Current Ratio10.30 Sales Q/Q-36.40% Oper. Margin- RSI (14)37.11 Volatility8.20% 16.95%
OptionableYes Debt/Eq0.00 EPS Q/Q13.20% Profit Margin- Rel Volume0.31 Prev Close0.42
ShortableYes LT Debt/Eq0.00 EarningsMay 22 AMC Payout- Avg Volume2.09M Price0.44
Recom2.00 SMA20-11.87% SMA50-42.56% SMA200-55.46% Volume272,456 Change4.05%
Dec-13-18Initiated H.C. Wainwright Buy $2.50
Nov-10-17Downgrade Raymond James Outperform → Mkt Perform
Jan-25-17Initiated Raymond James Outperform
Aug-11-15Downgrade Cantor Fitzgerald Buy → Hold
Jun-29-15Initiated Piper Jaffray Overweight $5
Jun-29-15Initiated Jefferies Buy $5
Jun-26-19 06:57AM  Investors are still embracing 3-D printing despite some big IPO misfires MarketWatch
Jun-25-19 08:37AM  Penny Stocks to Buy Using Technical Analysis for June 2019 Investopedia -6.14%
Jun-13-19 08:05AM  Organovo to Present at Raymond James Life Sciences and MedTech Conference GlobeNewswire
Jun-10-19 12:36PM  Options Traders Expect Huge Moves in Organovo (ONVO) Stock Zacks +25.06%
Jun-05-19 01:16AM  Edited Transcript of ONVO earnings conference call or presentation 22-May-19 9:00pm GMT Thomson Reuters StreetEvents -12.21%
May-30-19 08:05AM  Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease GlobeNewswire +103.36%
May-24-19 07:44AM  The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice Benzinga -14.62%
May-22-19 04:05PM  Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results GlobeNewswire
May-17-19 08:05AM  Organovo Announces Release Date for Preliminary Fiscal Fourth-Quarter 2019 Financial Results GlobeNewswire
Apr-26-19 01:01PM  The Organovo Holdings (NASDAQ:ONVO) Share Price Is Down 83% So Some Shareholders Are Rather Upset Simply Wall St.
Apr-17-19 08:05AM  Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean GlobeNewswire
Mar-14-19 08:05AM  Organovo to Participate in Nash Panel Discussion at 31st Annual Roth Conference GlobeNewswire
Feb-20-19 08:05AM  Organovo Appoints New Board Member GlobeNewswire
Feb-13-19 03:29AM  Edited Transcript of ONVO earnings conference call or presentation 7-Feb-19 10:00pm GMT Thomson Reuters StreetEvents +5.88%
Feb-12-19 07:45AM  Factors of Influence in 2019, Key Indicators and Opportunity within Fiserv, DTE Energy, Acacia Communications, Organovo, Presidio, and Power Integrations New Research Emphasizes Economic Growth GlobeNewswire
Feb-08-19 02:35PM  Organovo Holdings (ONVO) Q3 2019 Earnings Conference Call Transcript Motley Fool
Feb-07-19 06:40PM  Organovo (ONVO) Reports Q3 Loss, Misses Revenue Estimates Zacks
05:35PM  Organovo: Fiscal 3Q Earnings Snapshot Associated Press
04:05PM  Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results GlobeNewswire
Jan-31-19 10:31AM  Will Organovo (ONVO) Report Negative Earnings Next Week? What You Should Know Zacks
Jan-22-19 10:57AM  What Type Of Shareholder Owns Organovo Holdings, Inc.s (NASDAQ:ONVO)? Simply Wall St.
Jan-17-19 08:05AM  Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results GlobeNewswire
Dec-06-18 08:05AM  Organovo Appoints New Board Member GlobeNewswire
Dec-04-18 06:19PM  Edited Transcript of ONVO earnings conference call or presentation 8-Nov-18 10:00pm GMT Thomson Reuters StreetEvents
Nov-12-18 08:05AM  Organovo Partners With IIAM on Multi-Year Clinical Biomaterial Sourcing Agreement GlobeNewswire
Nov-08-18 07:30PM  Organovo (ONVO) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:27PM  Organovo: Fiscal 2Q Earnings Snapshot Associated Press
04:05PM  Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Second-Quarter 2019 Results GlobeNewswire
07:57AM  Organovo Q2 Earnings Preview Benzinga
Oct-18-18 08:05AM  Organovo Announces Release Date for Fiscal Second-Quarter 2019 Financial Results GlobeNewswire
Oct-17-18 07:30AM  Report: Exploring Fundamental Drivers Behind Shenandoah Telecommunications, Nova Measuring Instruments, FRP, National Fuel Gas, Organovo, and Sierra Wireless New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-15-18 08:05AM  Organovo to Present New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Tyrosinemia I at the Liver Meeting® 2018 (AASLD) GlobeNewswire
Sep-26-18 08:05AM  Organovo to Present at 2018 Cell & Gene Meeting on the Mesa GlobeNewswire
Sep-19-18 02:27PM  Is Organovo Holdings Incs (NASDAQ:ONVO) Balance Sheet A Threat To Its Future? Simply Wall St.
Aug-27-18 03:50PM  Edited Transcript of ONVO earnings conference call or presentation 9-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-14-18 08:15PM  Recent Analysis Shows Ellie Mae, Organovo, Calithera Biosciences, Whirlpool, Marathon Oil, and Infinera Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
05:00PM  Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-10-18 07:38AM  The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga -17.52%
Aug-09-18 07:20PM  Organovo (ONVO) Reports Q1 Loss, Misses Revenue Estimates Zacks +5.38%
06:12PM  Organovo: Fiscal 1Q Earnings Snapshot Associated Press
04:05PM  Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expands Key Clinical Development Goals GlobeNewswire
03:00PM  Organovo Holdings, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 08:05AM  Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer GlobeNewswire
Jul-20-18 07:25AM  Free Pre-Market Technical Recap on ResMed and Three Additional Healthcare Stocks ACCESSWIRE
Jul-19-18 08:05AM  Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results GlobeNewswire
Jun-05-18 12:03PM  Edited Transcript of ONVO earnings conference call or presentation 31-May-18 9:00pm GMT Thomson Reuters StreetEvents
Jun-01-18 03:04PM  Here's Why Organovo Holdings Stock Fell as Much as 28.4% Today Motley Fool -26.40%
May-31-18 04:30PM  Organovo: Fiscal 4Q Earnings Snapshot Associated Press
04:05PM  Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019 GlobeNewswire
07:57AM  Organovo Q4 Earnings Preview Benzinga
07:10AM  Free Stock Performance Review on Organovo Holdings and Three Additional Medical Research Stocks ACCESSWIRE
May-18-18 07:15PM  Want To Invest In Organovo Holdings Inc (NASDAQ:ONVO)? Heres How It Performed Lately Simply Wall St.
May-16-18 07:55AM  New Research Coverage Highlights Tyson Foods, Windstream, Laredo Petroleum, Idera Pharmaceuticals, Diamondrock Hospitality, and Organovo Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
May-14-18 08:05AM  Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results GlobeNewswire +5.44%
May-10-18 08:05AM  Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress GlobeNewswire +9.92%
May-03-18 08:05AM  Organovo and Samsara Sciences Partner with New Manufacturing USA Institute GlobeNewswire
Apr-18-18 09:50AM  Can The Uptrend Continue for Organovo Holdings (ONVO)? Zacks +5.31%
Apr-16-18 08:05AM  Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models GlobeNewswire
Apr-12-18 08:05AM  Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress GlobeNewswire
08:00AM  Cirius Therapeutics' Preclinical Data Demonstrates Potential for Lead Drug Candidate MSDC-0602K in NASH PR Newswire
Mar-26-18 08:05AM  Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions GlobeNewswire
Mar-15-18 08:05AM  Organovo to Present at H.C. Wainwright Nash Investor Conference GlobeNewswire
Mar-08-18 08:05AM  Organovo to Present at 30th Annual ROTH Conference GlobeNewswire
07:30AM  Report: Developing Opportunities within Owens & Minor, Zosano Pharma, Organovo, Summit Materials, Ralph Lauren, and Clearside Biomedical Future Expectations, Projections Moving into 2018 GlobeNewswire
Feb-09-18 09:56AM  Edited Transcript of ONVO earnings conference call or presentation 8-Feb-18 10:00pm GMT Thomson Reuters StreetEvents -6.82%
Feb-08-18 06:41PM  Organovo reports 3Q loss Associated Press
04:05PM  Organovo Announces Fiscal Third-Quarter 2018 Results; Company Updates Full-Year Fiscal 2018 Outlook GlobeNewswire
12:50PM  Organovo Holdings, Inc. to Host Earnings Call ACCESSWIRE
11:08AM  A Preview Of Organovo's Q3 Earnings Benzinga
Jan-18-18 08:05AM  Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results GlobeNewswire
Dec-28-17 12:34PM  ETFs with exposure to Organovo Holdings, Inc. : December 28, 2017 Capital Cube
Dec-27-17 08:53AM  Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q2, 2018 By the Numbers : December 27, 2017 Capital Cube -6.21%
Dec-26-17 08:05AM  Organovo Receives Orphan Designation From U.S. FDA for 3D Bioprinted Therapeutic Liver Tissue Treatment of Alpha-1 Antitrypsin Deficiency GlobeNewswire
Dec-20-17 07:49AM  Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, American Superconductor and Stratasys Zacks
Dec-19-17 06:23AM  Try Rising P/E Investing With 5 Top-Ranked Stocks Zacks
Dec-15-17 02:00PM  ETFs with exposure to Organovo Holdings, Inc. : December 15, 2017 Capital Cube
Dec-05-17 09:35AM  Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, Signal Genetics and Stratasys Zacks
Dec-03-17 02:48PM  Where Will Organovo Holdings, Inc. Be in 5 Years? Motley Fool
Nov-27-17 08:20AM  Report: Developing Opportunities within Social Reality, The Finish Line, Facebook, Organovo, Plug Power, and Intrexon Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-20-17 09:22AM  Zacks.com featured highlights: Fortuna Silver Mines, Ritter Pharmaceuticals , Organovo Holdings, Western Digital and Willdan Group Zacks
Nov-09-17 10:46PM  Edited Transcript of ONVO earnings conference call or presentation 9-Nov-17 10:00pm GMT Thomson Reuters StreetEvents
05:59PM  Organovo reports 2Q loss Associated Press
04:05PM  Organovo Announces Fiscal Second-Quarter 2018 Results; Company Shifts Commercial Focus to Higher-Value Disease Modeling Opportunities and Updates Full-Year Fiscal 2018 Outlook GlobeNewswire
Nov-06-17 08:05AM  Organovo and Viscient Biosciences Collaborate to Develop Custom Research Platform for Studying Liver Disease GlobeNewswire
Oct-30-17 12:08PM  ETFs with exposure to Organovo Holdings, Inc. : October 30, 2017 Capital Cube
Oct-20-17 10:21AM  ETFs with exposure to Organovo Holdings, Inc. : October 20, 2017 Capital Cube +15.00%
08:05AM  Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting® 2017 (AASLD) GlobeNewswire
Oct-19-17 08:05AM  Organovo Announces Release Date for Fiscal Second-Quarter 2018 Financial Results GlobeNewswire -5.41%
Oct-09-17 11:51AM  ETFs with exposure to Organovo Holdings, Inc. : October 9, 2017 Capital Cube
Oct-06-17 09:04AM  Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 6, 2017 Capital Cube
Oct-04-17 05:05PM  Organovo Announces Preliminary Fiscal Second-Quarter Total Revenue; Company Restructures to Improve Operational Efficiency GlobeNewswire -7.69%
Oct-03-17 12:16PM  When Will Organovo Holdings Inc (ONVO) Come Back To Market? Simply Wall St.
Aug-30-17 03:43PM  Why Tiny Organovo Is Giving Money to Huge Biotech Amgen Motley Fool
Aug-23-17 08:05AM  Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease GlobeNewswire
Aug-14-17 02:20PM  Edited Transcript of ONVO earnings conference call or presentation 9-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 06:14PM  ETFs with exposure to Organovo Holdings, Inc. : August 11, 2017 Capital Cube
Aug-10-17 08:24AM  Organovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters Motley Fool
Aug-09-17 11:54PM  Organovo reports 1Q loss Associated Press
04:05PM  Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook GlobeNewswire
01:00PM  Investor Network: Organovo Holdings, Inc. to Host Earnings Call ACCESSWIRE
Organovo Holdings, Inc., a biotechnology company, develops bioprinted human tissues based on its 3D human tissue platform technology that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases. In addition, the company offers preclinical in vitro disease modeling platforms, including a range of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis conditions. Further, it is involved in various programs to develop its NovoTissues to address various serious unmet medical needs primarily focusing on liver disease. Organovo Holdings, Inc. was founded in 2007 and is headquartered in San Diego, California.